Dr. Charles Wells | Source | Head of Therapeutics Development at Bill & Melinda Gates Medical Research In...
Dr. Charles Wells
As Head of Therapeutics Development at Gates MRI, Dr. Charles Wells drives end-to-end development of a diverse portfolio of small molecules and biologics for the treatment and prevention of diseases primarily affecting low-and-middle-income countries. He joined following leadership roles in the pharmaceutical industry and at the CDC. Dr. Wells is available to share his perspective on current challenges in eradicating Tuberculosis around the world and in the US and his insight on how to create a path forward.
-
Bill & Melinda Gates Medical Research Institute (https://www.gatesmri.org/)
Head of Therapeutics Development
started May 2019 -
Sanofi (https://www.sanofi.com/)
Associate Vice President, Infectious Diseases Therapeutic Area
Sep 2015 – Jul 2018
-
Gates Medical Research Institute as an integrator – our partnerships to help address the public health challenges posed by tuberculosis - MPP
Tuberculosis is a major cause of ill health and one of the leading causes of death worldwide. Prior to the advent of the COVID-19 pandemic, TB was the leading cause of death from a single infectious agent.
Article -
What does the future look like for TB care?
In this interview, we speak to Charles Wells from Gates MRI about their current research into tuberculosis (TB) as well as the recent updated guidelines for TB care.
Article
